HCM - Standard Biotools enters strategic engagement with Bristol Myers for expanded use of Somascan platform
2024-04-03 16:10:28 ET
More on Standard BioTools
- Standard BioTools Inc. (LAB) Q4 2023 Earnings Call Transcript
- Standard BioTools exchanges all outstanding Series B convertible preferred stock for common stock
- Standard BioTools expects over 10% growth in 2023 core revenue
- Seeking Alpha’s Quant Rating on Standard BioTools
- Historical earnings data for Standard BioTools